致敏患者肾移植的处理策略
被引量：1
Pretreatment strategies in sensitized recipients for kidney transplantation
摘要
随着肾移植例数的增长,近年来国内外各大移植中心的移植物功能丧失及致敏受者也迅速增多.2007年美国器官获取及移植网络（OPTN）和器官移植受体科学登记处（SRTR）的年报显示,在等待肾移植的患者中高致敏患者（群体反应性抗体≥80%）占15.8%.体内预存的高水平的抗HLA抗体不仅可诱发各种类型的排斥反应、延缓移植物功能恢复,而且还与移植物功能丧失相关.目前,对致敏受者的临床处理尚缺乏公认的理想措施,本文就有关问题进行探讨,以期为致敏受者的肾移植提供借鉴.
出处
《中华器官移植杂志》
CAS
CSCD
北大核心
2010年第6期325-327,共3页
Chinese Journal of Organ Transplantation
参考文献18
-
1Montgomery RA, Hardy MA,Jordan SC, et al. Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody mediated rejection and desensitization protocols. Transplantation, 2004,78 ( 2 ) : 181 - 185.
-
2Muro M, Llorente S, Marin L, et al. Acute vascular rejection mediated by HLA antibodies in a cadaverie kidney recipient:discrepancies between FlowPRA, ELISA and CDC vs luminex screening. Nephrol Dial Transplant, 2005,20( 1 ) : 223-226.
-
3Akalin E. Posttransplant immunosuppression in highly sensitized patients. Contrib Nephrol, 2009,162 : 27-34.
-
4Billen EV,Christiaans MH, van den Berg-Loonen EM. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants. Tissue Antigens,2009,74(3)205- 212.
-
5Jordan SC, Tyan D, Stablein D, et al. Evaluation of intravenous immunoglohulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol, 2004, / 5 (12) : 3256-3262.
-
6Jordan SC, Vo AA, Peng A, et al. Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA sensitized patients. Am J Transplant, 2006,6(3) :459- 466.
-
7Yoon HE, Hyoung BJ, Hwang HS, et al. Successful renal transplantation with desensitization in highly sensitized patients: a single center experience. J Korean Med Sei, 21)119, 24 Suppl : S148-155.
-
8Vo AA, Wechsler EA,Wang J, et al. Analysis of subcutaneous (SQ) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximab. Am J Transplant,2(108,8 (1) : 144-149.
-
9Mai ML,Ahsan N, Wadei HM, et al. Excellent renal allograft survival in donor-specific antibody positive transplant patients role of intravenous immunoglobulin and rabbit antithymocyte globulin. Transplantation, 2009,87 (2) 227-232.
-
10Amico P, Honger G, Steiger J, et al. Utility of the virtual crossmatch in solid organ transplantation. Curr Opin Organ Transplant,2009,14(6) : 656-661.
同被引文献9
-
1Vo AA, Lukovsky M, Toyoda M, et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med, 2008, 359(3):242-251.
-
2Vo AA, Peng A, Toyoda M, et al. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Transplantation, 2010, 89(9) : 1095-1102.
-
3Rose ML, West LJ. Accommodation: does it apply to human leukocyte antigens?. Transplantation, 2012, 93 (3) : 244-246.
-
4Jordan SC, Reinsmoen N, Lai CH, et al. Novel immunotherapeutic approaches to improve rates and Outcomes of transplantation in sensitized renal allograft recipients. Discov Med, 2012, 13(70) : 235-245.
-
5Mohan S, Palanisamy A, Tsapepas D, et al. Donor-specific antibodies adversely affect kidney allograft outcomes, j Am Soc Nephrol, 2012, 23(12):2061-2071.
-
6FehrT, Gaspert A. Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale. Transpl Int, 2012, 25(6) :623-632.
-
7Roberts DM, Jiang SH, Chadban SJ. The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review. Transplantation, 2012, 94(8):775-783.
-
8ZhangW, Chen D, Chen Z, et al. Successful kidney transplantation in highly sensitized patients. Front Med, 2011, 5(1):80-85.
-
9孙启全.移植肾急性体液性排斥的个体化治疗[J].肾脏病与透析肾移植杂志,2009,18(5):442-443. 被引量：1
引证文献1
-
1陈栋,张伟杰,陈刚,周平,昌盛,朱兰,陈松,施辉波,杜敦峰,陈知水.肾移植前对致敏患者干预治疗的方案及疗效分析[J].中华器官移植杂志,2013,34(4):202-205. 被引量：1
-
1贾保祥,张磊,田野.肾移植患者抗HLA抗体阳性与术后发生急性排斥关系的研究[J].现代检验医学杂志,2011,26(3):62-64. 被引量：5
-
2黄先恩,夏穗生.致敏受者肾移植急性体液排斥反应的诊断和防治[J].国外医学（移植与血液净化分册）,2004,2(2):20-22.
-
3许吕宏,洪冬玲,吴燕峰,方建培.间充质干细胞在致敏受者造血干细胞移植中的作用[J].中山大学学报（医学科学版）,2013,34(2):225-229. 被引量：1
-
4后平钦,李国良,唐绮,孙瑜,肖莉.PRA致敏患者抗体特异性及其动态观察[J].江西医学检验,2006,24(2):183-183. 被引量：1
-
5汪秀明,于惠元.抗HLA抗体对血管内皮细胞与淋巴细胞杀伤效应比较[J].中华器官移植杂志,1989,10(2):62-64.
-
6谢礼波,王莉,唐雯,宋涂润,卢一平,庄杰,代波,林涛.活体肾移植前对致敏患者的处理经验及疗效分析[J].中华器官移植杂志,2013,34(4):198-201.
-
7苗书斋,蔡文利,邢利,蒋欣,陈国勇,曲青山.致敏患者肾移植前的免疫吸附治疗16例[J].中华器官移植杂志,2009,30(3):186-187.
-
8潘荪,李军,王春生.人类白细胞抗原配型与群体反应性抗体检测在心脏移植中的应用进展[J].中国胸心血管外科临床杂志,2007,14(2):132-134.
-
9郑树森.中国移植器官保护专家共识（2016版）[J].中华普通外科杂志,2016,31(9):796-800.
-
10叶启翔,翁文俊,许吕宏,方建培.阻断共刺激信号途径对造血干细胞移植后致敏受者免疫耐受排斥的影响[J].中国实验血液学杂志,2014,22(1):131-135. 被引量：2
